Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 19 de 19
Filtrar
1.
BMJ Open ; 2(6)2012.
Artigo em Inglês | MEDLINE | ID: mdl-23204141

RESUMO

INTRODUCTION: Colonoscopies are being requested with increasing frequency in the last few years, as they are used both as a diagnostic and therapeutic procedure in several gastrointestinal diseases. Our purpose is to describe the appropriateness of colonoscopy requests issued both from primary care centres and from hospitals, according to the EPAGE II guidelines (European Panel on the Appropriateness of Gastrointestinal Endoscopy). METHODS AND ANALYSIS: Cross-sectional study. Colonoscopy requests issued since January 2011 and received at the endoscopy units of all six reference hospitals serving the primary care centres of the South Metropolitan and Central Catalonia districts will be collected (total=1500 requests). Variables to be collected include gender, date of birth, origin of the request and reference hospital, priority of the procedure, type of clinician requesting the procedure, date and indication of request, abdominal examination performed, anal inspection examination performed, date of last colonoscopy if applicable, diagnosis and date of diagnosis. Using the available information and the EPAGE II website, colonoscopy requests will be assigned as an appropriateness score. The association between the variables collected and the EPAGE II scores will be assessed using a Student's t test and a χ(2) test. A multilevel logistic model will be generated on the factors associated with the appropriateness of the requests. ETHICS AND DISSEMINATION: Colonoscopy is a costly procedure and not free from complications. In order to increase cost effectiveness, reduce waiting lists and optimise resources, it is necessary to use tools such as the EPAGE II guidelines, which establish criteria to assess the appropriateness of colonoscopies. The purpose of this study is to describe the current situation and to discuss whether current clinical practice is appropriate. The results of the study will be published in the next few years. In consideration of the ethical principles and methods of the research study, approval was granted for the project.

2.
Gastroenterol. hepatol. (Ed. impr.) ; 35(10): 725-738, Dic. 2012. ilus, tab
Artigo em Espanhol | IBECS | ID: ibc-106512

RESUMO

La finalidad de la Guía de Práctica Clínica (GPC) sobre el Manejo del Paciente con Dispepsia es generar unas recomendaciones acerca del manejo óptimo de la dispepsia en el ámbito de la atención primaria y especializada ambulatoria. Su objetivo principal es ayudar a optimizar el proceso diagnóstico, identificando a los pacientes con bajo riesgo de tener una patología orgánica grave (fundamentalmente tumoral), los cuales podrían ser manejados de forma segura sin necesidad de realizar pruebas diagnósticas invasivas y/o derivaciones al especialista. La importancia de este objetivo radica en la necesidad de no dejar de diagnosticar a los pacientes con un cáncer esófago-gástrico, tratar correctamente la úlcera péptica y, a la vez, reducir las endoscopias negativas para, en definitiva, utilizar de manera adecuada los recursos sanitarios disponibles. En esta GPC se revisan las posibles estrategias iniciales en el paciente con dispepsia no investigada, valorando la posible decisión de iniciar o no un tratamiento empírico o de investigar la existencia de una lesión que justifique los síntomas. Asimismo, en esta GPC se aborda la dispepsia funcional, la cual engloba a todos los pacientes con dispepsia sin una causa orgánica objetivable a través de la endoscopia. En esta GPC también se presentan las recomendaciones para el diagnóstico y tratamiento de la úlcera péptica y de la infección por Helicobacter pylori (AU)


The aim of the Clinical Practice Guideline (CPG) on the Management of Patients with Dyspepsia is to generate recommendations on the optimal approach to dyspepsia in the primary care and specialized outpatient setting. The main objective of this CPG is to help to optimize the diagnostic process, identifying patients with a low risk of a serious organic disease (mainlytumoral), who could be safely managed without the need for invasive diagnostic tests and/or referral to a specialist. The importance of this aim lies in the need to accurately diagnose patients with esophagogastric cancer and correctly treat peptic ulcer while, at the same time, reduce negative endoscopies in order to appropriately use the available healthcare resources. This CPG reviews the initial strategies that can be used in patients with uninvestigated dyspepsia and evaluates the possible decision to begin empirical therapy or to investigate the existence of a lesion that could explain the symptoms. This CPG also discusses functional dyspepsia, which encompasses all patients with dyspepsia with no demonstrable cause on endoscopy. Recommendations for the diagnosis and treatment of peptic ulcer and Helicobacter pylori infection are also made. To classify the scientific evidence and strengthen the recommendations, the GRADE (Grading of Recommendations Assessment, Development and Evaluation Working Group) system has been used (http://www.gradeworkinggroup.org/) (AU)


Assuntos
Humanos , Dispepsia/diagnóstico , Dispepsia/terapia , Helicobacter pylori/isolamento & purificação , Infecções por Helicobacter/epidemiologia , Padrões de Prática Médica , Endoscopia Gastrointestinal
3.
Aten. prim. (Barc., Ed. impr.) ; 44(12): 727-727[e1-e38], dic. 2012. ilus, tab, graf
Artigo em Espanhol | IBECS | ID: ibc-108135

RESUMO

La finalidad de la Guía de Práctica Clínica (GPC) sobre el Manejo del Paciente con Dispepsia es generar unas recomendaciones acerca del manejo óptimo de la dispepsia en el ámbito de la atención primaria y especializada ambulatoria. Su objetivo principal es ayudar a optimizar el proceso diagnóstico, identificando a los pacientes con bajo riesgo de tener una patología orgánica grave (fundamentalmente tumoral), los cuales podrían ser manejados de forma segura sin necesidad de realizar pruebas diagnósticas invasivas y/o derivaciones al especialista. La importancia de este objetivo radica en la necesidad de no dejar de diagnosticar a los pacientes con un cáncer esófago-gástrico, tratar correctamente la úlcera péptica y, a la vez, reducir las endoscopias negativas para, en definitiva, utilizar de manera adecuada los recursos sanitarios disponibles. En esta GPC se revisan las posibles estrategias iniciales en el paciente con dispepsia no investigada, valorando la posible decisión de iniciar o no un tratamiento empírico o de investigar la existencia de una lesión que justifique los síntomas. Asimismo, en esta GPC se aborda la dispepsia funcional, la cual engloba a todos los pacientes con dispepsia sin una causa orgánica objetivable a través de la endoscopia. En esta GPC también se presentan las recomendaciones para el diagnóstico y tratamiento de la úlcera péptica y de la infección por Helicobacter pylori. Para clasificar la evidencia científica y la fuerza de las recomendaciones se ha utilizado el sistema GRADE (Grading of Recommendations Assessment, Development and Evaluation Working Group) (http://www.gradeworkinggroup.org/)(AU)


The aim of the Clinical Practice Guideline (CPG) on the Management of Patients with Dyspepsia is to generate recommendations on the optimal approach to dyspepsia in the primary care and specialized outpatient setting. The main objective of this CPG is to help to optimize the diagnostic process, identifying patients with a low risk of a serious organic disease (mainly tumoral), who could be safely managed without the need for invasive diagnostic tests and/or referral to a specialist. The importance of this aim lies in the need to accurately diagnose patients with esophagogastric cancer and correctly treat peptic ulcer while, at the same time, reduce negative endoscopies in order to appropriately use the available healthcare resources. This CPG reviews the initial strategies that can be used in patients with uninvestigated dyspepsia and evaluates the possible decision to begin empirical therapy or to investigate the existence of a lesion that could explain the symptoms. This CPG also discusses functional dyspepsia, which encompasses all patients with dyspepsia with no demonstrable cause on endoscopy. Recommendations for the diagnosis and treatment of peptic ulcer and Helicobacter pylori infection are also made. To classify the scientific evidence and strengthen the recommendations, the GRADE (Grading of Recommendations Assessment, Development and Evaluation Working Group) system has been used (http://www.gradeworkinggroup.org/)(AU)


Assuntos
Humanos , Dispepsia/terapia , Protocolos Clínicos , Guias de Prática Clínica como Assunto , Dispepsia/diagnóstico , Dispepsia/economia , Planejamento de Assistência ao Paciente , Helicobacter pylori/patogenicidade , Fatores de Risco , Medicina Baseada em Evidências , Assistência Ambulatorial/normas , Atenção à Saúde/normas
4.
Gastroenterol Hepatol ; 35(10): 725.e1-38, 2012 Dec.
Artigo em Espanhol | MEDLINE | ID: mdl-23186826

RESUMO

The aim of the Clinical Practice Guideline (CPG) on the Management of Patients with Dyspepsia is to generate recommendations on the optimal approach to dyspepsia in the primary care and specialized outpatient setting. The main objective of this CPG is to help to optimize the diagnostic process, identifying patients with a low risk of a serious organic disease (mainly tumoral), who could be safely managed without the need for invasive diagnostic tests and/or referral to a specialist. The importance of this aim lies in the need to accurately diagnose patients with esophagogastric cancer and correctly treat peptic ulcer while, at the same time, reduce negative endoscopies in order to appropriately use the available healthcare resources.This CPG reviews the initial strategies that can be used in patients with uninvestigated dyspepsia and evaluates the possible decision to begin empirical therapy or to investigate the existence of a lesion that could explain the symptoms. This CPG also discusses functional dyspepsia, which encompasses all patients with dyspepsia with no demonstrable cause on endoscopy. Recommendations for the diagnosis and treatment of peptic ulcer and Helicobacter pylori infection are also made. To classify the scientific evidence and strengthen the recommendations, the GRADE (Grading of Recommendations Assessment, Development and Evaluation Working Group) system has been used (http://www.gradeworkinggroup.org/).


Assuntos
Dispepsia/diagnóstico , Dispepsia/terapia , Antibacterianos/uso terapêutico , Antiulcerosos/uso terapêutico , Gerenciamento Clínico , Dispepsia/etiologia , Gastrite/complicações , Gastrite/tratamento farmacológico , Gastrite/microbiologia , Gastroscopia , Infecções por Helicobacter/complicações , Infecções por Helicobacter/diagnóstico , Infecções por Helicobacter/tratamento farmacológico , Helicobacter pylori/isolamento & purificação , Antagonistas dos Receptores H2 da Histamina/uso terapêutico , Humanos , Educação de Pacientes como Assunto , Úlcera Péptica/tratamento farmacológico , Úlcera Péptica/microbiologia , Úlcera Péptica/cirurgia
5.
Aten Primaria ; 44(12): 727.e1-727.e38, 2012 Dec.
Artigo em Espanhol | MEDLINE | ID: mdl-23036729

RESUMO

The aim of the Clinical Practice Guideline (CPG) on the Management of Patients with Dyspepsia is to generate recommendations on the optimal approach to dyspepsia in the primary care and specialized outpatient setting. The main objective of this CPG is to help to optimize the diagnostic process, identifying patients with a low risk of a serious organic disease (mainly tumoral), who could be safely managed without the need for invasive diagnostic tests and/or referral to a specialist. The importance of this aim lies in the need to accurately diagnose patients with esophagogastric cancer and correctly treat peptic ulcer while, at the same time, reduce negative endoscopies in order to appropriately use the available healthcare resources. This CPG reviews the initial strategies that can be used in patients with uninvestigated dyspepsia and evaluates the possible decision to begin empirical therapy or to investigate the existence of a lesion that could explain the symptoms. This CPG also discusses functional dyspepsia, which encompasses all patients with dyspepsia with no demonstrable cause on endoscopy. Recommendations for the diagnosis and treatment of peptic ulcer and Helicobacter pylori infection are also made. To classify the scientific evidence and strengthen the recommendations, the GRADE (Grading of Recommendations Assessment, Development and Evaluation Working Group) system has been used (http://www.gradeworkinggroup.org/).


Assuntos
Dispepsia/diagnóstico , Dispepsia/terapia , Algoritmos , Dispepsia/epidemiologia , Dispepsia/microbiologia , Infecções por Helicobacter/complicações , Infecções por Helicobacter/tratamento farmacológico , Helicobacter pylori , Humanos
6.
Gastroenterol Hepatol ; 35(3): 109-28, 2012 Mar.
Artigo em Espanhol | MEDLINE | ID: mdl-22365571

RESUMO

Colorectal cancer (CRC) is the most common malignant tumor in Spain, when men and women are considered together, and the second leading cause of cancer death. Every week in Spain over 500 cases of CRC are diagnosed, and nearly 260 people die from the disease. Epidemiologic estimations for the coming years show a significant increase in the number of annual cases. CRC is a perfectly preventable tumor and can be cured in 90% of cases if detected in the early stages. Population-based screening programs have been shown to reduce the incidence of CRC and mortality from the disease. Unless early detection programs are established in Spain, it is estimated that in the coming years, 1 out of 20 men and 1 out of 30 women will develop CRC before the age of 75. The Alliance for the Prevention of Colorectal Cancer in Spain is an independent and non-profit organization created in 2008 that integrates patients' associations, altruistic non-governmental organizations and scientific societies. Its main objective is to raise awareness and disseminate information on the social and healthcare importance of CRC in Spain and to promote screening measures, early detection and prevention programs. Health professionals, scientific societies, healthcare institutions and civil society should be sensitized to this highly important health problem that requires the participation of all sectors of society. The early detection of CRC is an issue that affects the whole of society and therefore it is imperative for all sectors to work together.


Assuntos
Neoplasias Colorretais/prevenção & controle , Promoção da Saúde/organização & administração , Disseminação de Informação , Organizações sem Fins Lucrativos/organização & administração , Colonoscopia/normas , Neoplasias Colorretais/epidemiologia , Comportamento Cooperativo , Detecção Precoce de Câncer , Saúde Global , Objetivos , Educação em Saúde/organização & administração , Prioridades em Saúde , Humanos , Incidência , Programas de Rastreamento , Sangue Oculto , Organizações/organização & administração , Guias de Prática Clínica como Assunto , Setor Privado , Setor Público , Grupos de Autoajuda/organização & administração , Sociedades Médicas/organização & administração , Sociedades Científicas/organização & administração , Espanha/epidemiologia
8.
BMC Cancer ; 11(1): 408, 2011 Sep 25.
Artigo em Inglês | MEDLINE | ID: mdl-21942990

RESUMO

ABSTRACT: BACKGROUND: The aim of this study was to assess the extent of knowledge of primary health care (PHC) patients about colorectal cancer (CRC), their attitudes toward population-based screening for this disease and gender differences in these respects. METHODS: A questionnaire-based survey of PHC patients in the Balearic Islands and some districts of the metropolitan area of Barcelona was conducted. Individuals between 50 and 69 years of age with no history of CRC were interviewed at their PHC centers. RESULTS: We analyzed the results of 625 questionnaires, 58% of which were completed by women. Most patients believed that cancer diagnosis before symptom onset improved the chance of survival. More women than men knew the main symptoms of CRC. A total of 88.8% of patients reported that they would perform the fecal occult blood test (FOBT) for CRC screening if so requested by PHC doctors or nurses. If the FOBT was positive and a colonoscopy was offered, 84.9% of participants indicated that they would undergo the procedure, and no significant difference by gender was apparent. Fear of having cancer was the main reason for performance of an FOBT, and also for not performing the FOBT, especially in women. Fear of pain was the main reason for not wishing to undergo colonoscopy. Factors associated with reluctance to perform the FOBT were: (i) the idea that that many forms of cancer can be prevented by exercise and, (ii) a reluctance to undergo colonoscopy if an FOBT was positive. Factors associated with reluctance to undergo colonoscopy were: (i) residence in Barcelona, (ii) ignorance of the fact that early diagnosis of CRC is associated with better prognosis, (iii) no previous history of colonoscopy, and (iv) no intention to perform the FOBT for CRC screening. CONCLUSION: We identified gaps in knowledge about CRC and prevention thereof in PHC patients from the Balearic Islands and the Barcelona region of Spain. If fears about CRC screening, and CRC per se, are addressed, and if it is emphasized that CRC is preventable, participation in CRC screening programs may improve.

9.
Gastroenterol Hepatol ; 32(6): 431-64, 2009.
Artigo em Espanhol | MEDLINE | ID: mdl-19757508
16.
BMC Health Serv Res ; 6: 138, 2006 Oct 23.
Artigo em Inglês | MEDLINE | ID: mdl-17059600

RESUMO

BACKGROUND: The GRADE method represents a new approach to grading the quality of evidence and strength of recommendations in the preparation of Clinical Practice Guidelines (CPG). In the context of a pilot study to assess the implementability of the system in Spain, we considered it relevant to gain an insight into the significance of the perceptions and attitudes expressed by the actual experts participating in the system try-out. METHODS: Qualitative research with an ethnographic approach, through non-participant observation and focus groups within the context of a consensus workshop in which 19 CPG experts participated to evaluate the GRADE proposal using 12 evidence tables taken from hypertension, asthma and arthritis CPGs. The interventions were recorded, under a guarantee of confidentiality. The transcriptions and field notes were analyzed, based on a sociological discourse analysis model, and the provisional findings were re-sent to participants in order to improve their validity. RESULTS: 1) Certain problems over procedure and terminology hindered the acceptance of this new method as a common reference system for the preparation of CPGs. 2) A greater closeness to clinical practice was accompanied by concerns over value judgments and subjectivity, with a demand for greater explicitness in the consensus process. 3) The type of "evidence" on which the guidelines are based, how and by whom the evidence is prepared, and what the role of the different actors should be, all constitute unresolved concerns in the CPG preparation and implementation processes. 4) The grading process is not neutral: professional background, prior experience and the degree of leadership all condition the participants' input and interactions. CONCLUSION: The findings obtained allow the quantitative evaluation to be better interpreted and, in turn, go beyond the particularities of the GRADE method. Adaptation to the complexities of clinical practice, the need for carefully designed multi-disciplinary work and the reflexivity present in the CPG preparation process, all represent lines of debate that are necessary to improve the CPG quality in the Spanish health care sector.


Assuntos
Conferências de Consenso como Assunto , Consenso , Guias de Prática Clínica como Assunto , Antropologia Cultural/métodos , Artrite Reumatoide/diagnóstico , Artrite Reumatoide/terapia , Asma/diagnóstico , Asma/terapia , Medicina Baseada em Evidências/métodos , Implementação de Plano de Saúde , Humanos , Hipertensão/diagnóstico , Hipertensão/terapia , Pesquisa Qualitativa , Reprodutibilidade dos Testes , Espanha
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...